biopharmaceuticals

Peptide Manufacturing Scale-Up Guide

In November 2023, Novo Nordisk committed $6 billion to expanding its Danish facility—not to improve a drug's efficacy, but to scale peptide manufacturing to meet global demand that had far exceeded production capacity.